Creative Planning Vascular Biogenics Ltd. Transaction History

Creative Planning

  • $93.6 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 23, 2020
SELL
$1.12 - $1.63 $23,520 - $34,230
-21,000 Closed
0 $0
Q4 2019

Jan 30, 2020
SELL
$1.1 - $1.32 $1,100 - $1,320
-1,000 Reduced 4.55%
21,000 $25,000
Q3 2018

Oct 25, 2018
SELL
$1.55 - $2.17 $155 - $217
-100 Reduced 0.45%
22,000 $36,000
Q2 2018

Jul 20, 2018
BUY
$2.05 - $3.0 $10,455 - $15,300
5,100 Added 30.0%
22,100 $49,000
Q1 2018

Apr 18, 2018
BUY
$2.27 - $8.5 $38,590 - $144,500
17,000 New
17,000 $39,000

Others Institutions Holding VBLT

# of Institutions
2
Shares Held
416K
Call Options Held
0
Put Options Held
0
View Full List

About Vascular Biogenics Ltd.

VBLT Quotes by TradingView
  • Ticker VBLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,348,896
  • Description
  • Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...
More about VBLT
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email